Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$302K Buy
166,595
+31,135
+23% +$53.8K ﹤0.01% 2336
2025
Q4
$183K Buy
135,460
+55,305
+69% +$78.7K ﹤0.01% 2605
2025
Q3
$131K Buy
80,155
+43,341
+118% +$48K ﹤0.01% 2512
2025
Q2
$35.7K Buy
36,814
+24,460
+198% +$20.3K ﹤0.01% 2765
2025
Q1
$8.73K Buy
12,354
+12,350
+308,750% +$8.54K ﹤0.01% 3148
2024
Q4
$3 Buy
+4
New +$4 ﹤0.01% 3889
2024
Q3
Sell
-317
Closed -$491 3906
2024
Q2
$491 Hold
317
﹤0.01% 3570
2024
Q1
$520 Hold
317
﹤0.01% 3581
2023
Q4
$182 Hold
317
﹤0.01% 3611
2023
Q3
$127 Buy
+317
New +$157 ﹤0.01% 3353

Other funds holding OCGN

NewEdge Advisors's OCGN Position: Q1 2026 in Review

NewEdge Advisors increased its Ocugen (OCGN) stake by 23% in Q1 2026, buying an estimated $53.8K and bringing the position to 166,595 shares worth $302K. The position accounts for ﹤0.01% of the portfolio, ranked #2336.

NewEdge Advisors first reported a position in OCGN in Q3 2023 and has held it in 10 quarters since. 137 funds tracked by Wall St. Rank hold OCGN as of Q1 2026.

  • NewEdge Advisors held 166,595 shares of Ocugen worth $302K as of Q1 2026.
  • NewEdge Advisors bought 31,135 Ocugen shares in Q1 2026, an estimated $53.8K.
  • Ocugen made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #2336 holding.
  • NewEdge Advisors first reported a position in Ocugen in Q3 2023 and has held it in 10 quarters since.
  • 137 funds tracked by Wall St. Rank held Ocugen as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.